{"component": "definition", "props": {"groups": [{"samples": [{"hash": "dTLZJguaPhj", "uri": "/contracts/dTLZJguaPhj#methods-of-analysis", "label": "Manufacturing Agreement (Paratek Pharmaceuticals, Inc.)", "score": 29.5831622177, "published": true}, {"hash": "iLJaFTthenm", "uri": "/contracts/iLJaFTthenm#methods-of-analysis", "label": "Manufacturing and Services Agreement (Paratek Pharmaceuticals, Inc.)", "score": 28.3401779603, "published": true}, {"hash": "25S1IoeVp8l", "uri": "/contracts/25S1IoeVp8l#methods-of-analysis", "label": "Manufacturing and Services Agreement (Paratek Pharmaceuticals, Inc.)", "score": 28.1649555099, "published": true}], "snippet": "means the methods of analysis for the Products set forth in the Quality Agreement, as such Quality Agreement may be amended from time to time in accordance with its terms.", "size": 10, "snippet_links": [{"key": "the-products", "type": "clause", "offset": [34, 46]}, {"key": "quality-agreement", "type": "clause", "offset": [64, 81]}, {"key": "agreement-may-be-amended", "type": "clause", "offset": [99, 123]}, {"key": "from-time-to-time", "type": "clause", "offset": [124, 141]}, {"key": "in-accordance-with", "type": "definition", "offset": [142, 160]}], "hash": "d6e65960856d936cb574b3007b07f442", "id": 1}, {"samples": [{"hash": "e1osJmpJ03S", "uri": "/contracts/e1osJmpJ03S#methods-of-analysis", "label": "Development, License and Supply Agreement (Impax Laboratories Inc)", "score": 21.0, "published": true}, {"hash": "1H73CZ3Zju8", "uri": "/contracts/1H73CZ3Zju8#methods-of-analysis", "label": "Development, License and Supply Agreement (Impax Laboratories Inc)", "score": 21.0, "published": true}, {"hash": "3w7nQI6tM5X", "uri": "/contracts/3w7nQI6tM5X#methods-of-analysis", "label": "Development, License and Supply Agreement (Impax Laboratories Inc)", "score": 18.0, "published": true}], "snippet": "means the regulatory analytical test methods for the D-12 Product set forth in ANDA 76-050 and for the D-24 Product set forth in ANDA 75-989, as the same may be amended from time to time in accordance with the provisions of Section 5.3.", "size": 4, "snippet_links": [{"key": "analytical-test-methods", "type": "clause", "offset": [21, 44]}, {"key": "product-set", "type": "clause", "offset": [58, 69]}, {"key": "from-time-to-time", "type": "clause", "offset": [169, 186]}, {"key": "in-accordance-with", "type": "definition", "offset": [187, 205]}, {"key": "section-53", "type": "clause", "offset": [224, 235]}], "hash": "86b584586f74a43a03ef6583746459ad", "id": 2}, {"samples": [{"hash": "9WedVJaIrFJ", "uri": "/contracts/9WedVJaIrFJ#methods-of-analysis", "label": "License and Supply Agreement (Access Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "4ieIp7DvulF", "uri": "https://investors.abeonatherapeutics.com/all-sec-filings/content/0000318306-04-000016/0000318306-04-000016.pdf", "label": "investors.abeonatherapeutics.com", "score": 13.1460642187, "published": false}], "snippet": "means the methods of analysis for the Product which are mutually agreed upon in writing between the Parties and, on a date to be mutually agreed upon by the Parties, attached as an exhibit to the development plan (which development plan shall be agreed upon in accordance with Section 2.10).", "size": 2, "snippet_links": [{"key": "the-product", "type": "clause", "offset": [34, 45]}, {"key": "mutually-agreed", "type": "definition", "offset": [56, 71]}, {"key": "in-writing", "type": "definition", "offset": [77, 87]}, {"key": "between-the-parties", "type": "clause", "offset": [88, 107]}, {"key": "by-the-parties", "type": "clause", "offset": [150, 164]}, {"key": "the-development-plan", "type": "clause", "offset": [192, 212]}, {"key": "in-accordance-with", "type": "definition", "offset": [258, 276]}], "hash": "9f5fba0f1612be0152b5977374e9500e", "id": 3}, {"samples": [{"hash": "eVWlgUeGrZg", "uri": "/contracts/eVWlgUeGrZg#methods-of-analysis", "label": "Sales Agreement (Huntsman International Holdings LLC)", "score": 21.0, "published": true}, {"hash": "3uuI5odIWO8", "uri": "/contracts/3uuI5odIWO8#methods-of-analysis", "label": "Sales Agreement (Huntsman International LLC)", "score": 21.0, "published": true}], "snippet": "All analyses shall be made by the methods outlined in Exhibit \"B\"\u2014Procedure \"SAP S-009\", Exhibit \"C\"\u2014Procedure \"SAP S-010\", Exhibit \"D\"\u2014Procedures \"SAP S-003\", Exhibit \"E\"\u2014Procedure \"SAP S-102\", which are attached hereto and made a part hereof or by such other methods as QIT shall consider appropriate provided that the results obtained from such other methods are consistent with the results which would be obtained by using the methods outlined in the above-mentioned exhibits.", "size": 2, "snippet_links": [{"key": "other-methods", "type": "clause", "offset": [255, 268]}, {"key": "provided-that", "type": "clause", "offset": [303, 316]}, {"key": "consistent-with-the", "type": "clause", "offset": [366, 385]}], "hash": "84b72c0637bd11792dd644cb058ebd72", "id": 4}, {"samples": [{"hash": "8wQbxib4dg6", "uri": "/contracts/8wQbxib4dg6#methods-of-analysis", "label": "Supply Agreement (Amphastar Pharmaceuticals, Inc.)", "score": 21.0, "published": true}, {"hash": "3DdaZmV9pID", "uri": "/contracts/3DdaZmV9pID#methods-of-analysis", "label": "Supply Agreement (Amphastar Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "snippet": "means (a) if WYETH elects to proceed with Option A, the methods of analysis for the Product set forth in WYETH's NDA or (b) if WYETH elects to proceed with Option B, the methods of analysis for the Product set forth in \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587'\u2587 \u2587\u2587\u2587\u2587 and the additional Methods of Analysis set forth in Exhibit A attached hereto; in either case as the same may be amended from time to time in accordance with Article 6.", "size": 2, "snippet_links": [{"key": "option-a", "type": "definition", "offset": [42, 50]}, {"key": "product-set", "type": "clause", "offset": [84, 95]}, {"key": "option-b", "type": "definition", "offset": [156, 164]}, {"key": "in-\u2587", "type": "clause", "offset": [216, 220]}, {"key": "exhibit-a", "type": "clause", "offset": [288, 297]}, {"key": "from-time-to-time", "type": "clause", "offset": [357, 374]}, {"key": "in-accordance-with", "type": "definition", "offset": [375, 393]}, {"key": "article-6", "type": "definition", "offset": [394, 403]}], "hash": "32440071cf22165f198a6025b2075eaf", "id": 5}, {"samples": [{"hash": "k5wKAOhaxhy", "uri": "/contracts/k5wKAOhaxhy#methods-of-analysis", "label": "License and Supply Agreement (Uluru Inc.)", "score": 21.0, "published": true}, {"hash": "kDdHYuTxpKw", "uri": "http://pdf.secdatabase.com/603/0001168220-07-000052.pdf", "label": "pdf.secdatabase.com", "score": 19.7745147897, "published": false}], "snippet": "means the methods of analysis for the Product which is mutually agreed upon in writing between the Parties and, on a date to be mutually agreed upon by the Parties", "size": 2, "snippet_links": [{"key": "the-product", "type": "clause", "offset": [34, 45]}, {"key": "mutually-agreed", "type": "definition", "offset": [55, 70]}, {"key": "in-writing", "type": "definition", "offset": [76, 86]}, {"key": "between-the-parties", "type": "clause", "offset": [87, 106]}, {"key": "by-the-parties", "type": "clause", "offset": [149, 163]}], "hash": "55fc4afcf238fdb84fa5881204c73db9", "id": 6}, {"samples": [{"hash": "du9XDOeeo1e", "uri": "/contracts/du9XDOeeo1e#methods-of-analysis", "label": "Collaboration Agreement (Marinus Pharmaceuticals Inc)", "score": 32.8548939083, "published": true}], "snippet": "means the methods of analysis for the Product set forth in the Regulatory Dossier for the Product and/or the Quality Agreement.", "size": 2, "snippet_links": [{"key": "product-set", "type": "clause", "offset": [38, 49]}, {"key": "regulatory-dossier", "type": "definition", "offset": [63, 81]}, {"key": "quality-agreement", "type": "clause", "offset": [109, 126]}], "hash": "9288839bb81ae5dd7ff7a82e76559530", "id": 7}, {"samples": [{"hash": "eUPsazG32gL", "uri": "/contracts/eUPsazG32gL#methods-of-analysis", "label": "Exclusive License and Supply Agreement (Uluru Inc.)", "score": 24.8685831622, "published": true}], "snippet": "means the methods of analysis for the Product contained in the CE \u2587\u2587\u2587\u2587 filing.", "size": 2, "snippet_links": [{"key": "the-product", "type": "clause", "offset": [34, 45]}, {"key": "contained-in", "type": "definition", "offset": [46, 58]}], "hash": "2c4dda20a04af934645c05bbb568a319", "id": 8}, {"samples": [{"hash": "3fJUAFL4qIW", "uri": "/contracts/3fJUAFL4qIW#methods-of-analysis", "label": "Contract Manufacturing Agreement (Sol-Gel Technologies Ltd.)", "score": 33.2546201232, "published": true}], "snippet": "means the methods of analysis for the Product as agreed in writing between the Parties.", "size": 2, "snippet_links": [{"key": "the-product", "type": "clause", "offset": [34, 45]}, {"key": "as-agreed", "type": "clause", "offset": [46, 55]}, {"key": "in-writing", "type": "definition", "offset": [56, 66]}, {"key": "between-the-parties", "type": "clause", "offset": [67, 86]}], "hash": "500a33d85b497027ec15324843f037d8", "id": 9}, {"samples": [{"hash": "hsQN2Lvmg8a", "uri": "/contracts/hsQN2Lvmg8a#methods-of-analysis", "label": "Collaboration and Distribution Agreement (Forest Laboratories Inc)", "score": 23.1054072553, "published": true}], "snippet": "means the methods of analysis established by Nycomed, on the basis of which the compliance of Bulk Product with the related Product Specifications and Legal Requirements is determined and that shall form part of the Product Specifications.", "size": 1, "snippet_links": [{"key": "basis-of", "type": "clause", "offset": [61, 69]}, {"key": "bulk-product", "type": "definition", "offset": [94, 106]}, {"key": "specifications-and-legal-requirements", "type": "clause", "offset": [132, 169]}, {"key": "the-product", "type": "clause", "offset": [212, 223]}], "hash": "3232552984d12bbfc3aecd241b7b06a5", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIcbWV0aG9kcy1vZi1hbmFseXNpcyMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means the methods of analysis for the Products set forth in the Quality Agreement, as such Quality Agreement may be amended from time to time in accordance with its terms.", "size": 32, "title": "Methods of Analysis", "id": "methods-of-analysis", "examples": ["If controversy occurs, analysis shall be made in accordance with the method specified for \u201cSalt\u201d in the current \u201cOfficial <strong>Methods of Analysis</strong> for the Association of Official Agricultural Chemists\u201d.", "The requesting Party shall provide the other Party with a detailed written report of all proposed changes to the Manufacturing process, the Manufacturing equipment, the Specifications, the Materials, the sources of Materials or the <strong>Methods of Analysis</strong>.", "If either Party requests in writing a change in the Manufacturing process, the Manufacturing equipment, the Specifications, the Materials, the source of Materials or <strong>Methods of Analysis</strong> with respect to the Product that is not the result of a requirement of the FDA or any other Regulatory Authority, the other Party shall use commercially reasonable efforts to make or accept such change, as the case may be.", "Please refer to Item 8 - <strong>Methods of Analysis</strong>, Investment Strategies and Risk of Loss for more information.", "If, after good faith attempt by the Parties to do so, such consultation does not resolve the discrepancy, an independent, reputable laboratory designated by Purchaser shall repeat the applicable <strong>Methods of Analysis</strong> on representative samples from such delivery of Licensed Adjuvant provided by or for Purchaser.", "Once established pursuant to the Quality Agreement, the <strong>Methods of Analysis</strong> will be considered as Exhibit C attached hereto and shall be incorporated herein by reference.", "Purchaser may test the Licensed Adjuvant samples in accordance with the applicable <strong>Methods of Analysis</strong>.", "The <strong>Methods of Analysis</strong> may be amended from time to time in accordance with this Agreement Supplier shall promptly, upon completion of such tests, deliver to Purchaser a copy of the record of such tests performed on, and a Certificate of Analysis for, each shipment of Licensed Adjuvant to Purchaser.", "IMPAX shall perform the quality control tests with respect to Products in accordance with the <strong>Methods of Analysis</strong>, the cost of the same to be included in the price hereinafter specified.", "If either Party requests in writing a change in the Manufacturing process, the Manufacturing equipment, the Specifications, the Materials, the source of Materials or <strong>Methods of Analysis</strong> with respect to any Product that is not the result of a requirement of FDA or any other Regulatory Authority, the other Party shall use Commercially Reasonable Efforts to make or accept such change, as the case may be."], "related": [["risk-analysis", "risk analysis", "risk analysis"], ["sample", "Sample", "Sample"], ["certificate-of-analysis", "Certificate of Analysis", "Certificate of Analysis"], ["forensic-analysis", "Forensic analysis", "Forensic analysis"], ["market-analysis", "Market Analysis", "Market Analysis"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}